Search results
Moderna’s CEO shares what it was like to leap from pre-revenue startup to household name and Fortune...
Fortune via Yahoo Finance· 1 year agoOn this week’s episode of Fortune‘s Leadership Next podcast, co-hosts Alan Murray and Michal Lev-Ram...
Moderna CEO: Not everyone will need an annual COVID booster
Yahoo Finance· 2 years agoThe COVID-19 booster market is starting to look more like an annual flu season than it did in the...
Moderna Q3 earnings miss blamed on slow global demand, manufacturing constraints
Yahoo Finance· 2 years agoModerna (MRNA) reported its first miss in several quarters on slower demand and production issues...
Sanders to grill Moderna CEO over proposed COVID vaccine price hike
The Hill via Yahoo News· 1 year agoSen. Bernie Sanders (I-Vt.) plans to question the CEO of Moderna during a hearing next month about...
Is Moderna Stock a Buy After Its Impressive Cancer Vaccine Results?
Motley Fool· 2 years agoModerna (NASDAQ: MRNA) delivered its biggest one-day gain in a long time on Tuesday. Its shares...
Moderna says its RSV vaccine is 84% effective in older adults
Live Science via Yahoo News· 1 year agoolder man wearing a blue surgical mask looks down at his arm, which bears a bandage as if he's just...
Pfizer, Moderna push the new COVID booster. Should you get it? The CDC is about to decide.
The Desert Sun via Yahoo News· 9 months agoA small percentage of Americans got the most recent COVID-19 booster shot, and even fewer probably...
Moderna says its RSV vaccine for older adults is 84% effective at preventing serious illness
ABC News via Yahoo News· 1 year agoModerna's respiratory syncytial virus, or RSV, vaccine for older adults was about 84% effective at...
Moderna seeks FDA OK for updated COVID-19 booster
The Hill via Yahoo News· 2 years agoModerna on Tuesday said it submitted a request for the Food and Drug Administration (FDA) to authorize an updated version of its COVID-19 vaccine...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters via Yahoo News· 3 weeks ago(Reuters) -The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus...